07:00
2026-09-18
fortune.com
artificial-intelligence
Insilico Medicine’s Alex Zhavoronkov bets China and AI can deliver the drug industry’s next breakthrough
Insilico Medicine announced that its AI-discovered drug rentosertib, a treatment for idiopathic pulmonary fibrosis, will begin Phase 3 trials in China, with the first patient dosed on Sept. 10, accord…